Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study of Tarlatamab maintenance treatment after chemotherapy and radiation therapy in patients with limited stage small cell lung cancer who cannot receive both treatments together

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study on Toripalimab and Tifcemalimab for Patients with Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy

    Recruiting

    3 1
    Investigated Drugs:
    Belgium France Germany Italy The Netherlands Poland +2
  • A Phase III Randomized Trial of Trilaciclib Dihydrochloride versus Placebo in Adults with Limited‑Stage Small Cell Lung Cancer

    Not yet recruiting

    3 1
    Belgium Czechia France Greece Spain
  • Durvalumab after chemoradiation for patients with limited‑stage small cell lung cancer: a randomized trial of high‑dose versus standard thoracic radiation

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Estonia Finland Germany Lithuania The Netherlands +2
  • Study on the Effectiveness and Safety of Cisplatin, Carboplatin, Etoposide, and Durvalumab in Patients with Limited Stage Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Germany
  • Durvalumab Maintenance Therapy for Frail Patients with Limited Stage Small Cell Lung Cancer After Chemoradiotherapy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    France
  • Study of Tarlatamab for Patients with Limited-Stage Small-Cell Lung Cancer After Chemoradiotherapy

    Not recruiting

    3 1 1
    Austria Belgium Bulgaria France Germany Greece +6
  • Study of Pembrolizumab and Olaparib with Chemoradiation for Patients with Newly Diagnosed Limited-Stage Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    Belgium Bulgaria Estonia France Greece Hungary +5